CORPORATE
REPORT
2024Corporate Report Online
Message
Round-table Discussion
Transforming to a three-person governance structure: Big step together toward a Global Specialty Pharma
- Masao Nomura Outside Director (center)
- Akiko Okuno Outside Director (left)
- Shusaku Nagae Outside Director (right)
The three members, all of whom are Outside Directors and members of the Executive Appointment Meeting, discussed the governance structure, including the succession plan, and their vision for the realization of a Global Specialty Pharma.
Material Issues (Priority Management Issues)
Financial Strategy and
Medium-to Long-Term Investment Policy
